Human Metapneumovirus Infections Following Hematopoietic Cell Transplantation: Factors Associated With Disease Progression
Author(s) -
Sachiko Seo,
Ted Gooley,
Jane Kuypers,
Zachary Stednick,
Keith R. Jerome,
Janet A. Englund,
Michael Boeckh
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw284
Subject(s) - human metapneumovirus , medicine , hazard ratio , viral load , hematopoietic stem cell transplantation , transplantation , gastroenterology , lower respiratory tract infection , respiratory tract infections , lung transplantation , immunology , bronchoalveolar lavage , respiratory system , lung , confidence interval , virus
Human metapneumovirus (HMPV) is a newly identified pulmonary pathogen that can cause fatal lower respiratory tract disease (LRD) in hematopoietic cell transplantation (HCT) recipients. Little is known about progression rates from upper respiratory tract infection (URI) to LRD and risk factors associated with progression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom